Emma Walmsley

The podcast features Emma Walmsley, the CEO of GSK, Daniel Kahneman, a Nobel prize-winning psychologist, and Claire Hughes-Johnson, the one-time COO of Stripe. They discuss lessons in leadership outside the office, the importance of leadership and clarity, the value of being explicit as a manager, and the significance of stepping back and effective leadership.

Andrew Palmer learns leadership lessons from CEO of GSK, Emma Walmsley; Nobel prize-winning psychologist, Daniel Kahneman; and one-time COO of Stripe, Claire Hughes-Johnson. Topics discussed include leadership experiments, defining company purpose, effective decision-making, being explicit as a manager, improving team performance, and reflections on leadership challenges.

In this engaging discussion, Emma Walmsley, CEO of GSK and a key player in pharmaceuticals, shares insights on drug discovery and the integration of AI in speeding up medical advancements. She highlights GSK's breakthroughs in cancer treatments and respiratory medicine, while tackling the challenges of drug pricing and access. Emma also emphasizes the need for culture change within companies to foster innovation and accountability, and the significance of curiosity in leadership. Tune in for a captivating look at the future of healthcare!

Emma Walmsley, CEO of GlaxoSmithKline, discusses pivotal industry expectations regarding tariffs and innovations in specialty medicines. She shares insights on the rapidly evolving pharmaceutical landscape, emphasizing the impact of regulatory changes and groundbreaking drug developments. The conversation also highlights Hershey's CEO transition and challenges in the confectionery market, such as rising cocoa prices and changing consumer habits. Additionally, the outlook for tech giants is analyzed as major earnings reports loom, underscoring the competitive dynamics shaping various sectors.

Emma Walmsley, CEO of GSK and a leader in the pharmaceutical sector, shares fascinating insights on drug discovery and company culture. She discusses GSK's innovative advancements in cancer treatments and HIV therapies. Emma highlights the transformative role of AI in speeding up drug development. She emphasizes the importance of balancing drug accessibility and pricing, alongside the necessity of curiosity and partnership in navigating change. Tune in for her vision on reshaping healthcare for billions around the globe!